Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal of shareholdings in Euroclear plc

24 Oct 2017 17:37

RNS Number : 5129U
Royal Bank of Scotland Group PLC
24 October 2017
 

Royal Bank of Scotland Group PLC

24 October 2017

 

Disposal of shareholdings in Euroclear plc

 

The Royal Bank of Scotland Group plc ("RBS") announces that its subsidiaries have today entered into an agreement to dispose of RBS' entire shareholdings in Euroclear plc to IntercontinentalExchange Holdings.

 

The transaction, which was also completed today, involved the sale of 148,349 ordinary shares in Euroclear plc for a total cash consideration of €275 million (approximately £245 million at current exchange rates)*. KPMG Corporate Finance acted as financial advisers to RBS and Simmons & Simmons acted as legal advisers to RBS on this transaction.

 

The sale proceeds will be used for general corporate purposes. The transaction is part of the continued reduction of assets in RBS and is in line with the bank's plan to strengthen its capital position.The carrying value of the shareholding in Euroclear plc as at 30 June 2017 was approximately £88 million, which represents RWA equivalent of around £220 million. The transaction is expected to generate a gain of approximately £175 million after associated costs, reserves recycling and before tax, which will be recognised as a gain on strategic disposal in Q4 2017.

 

For further information, please contact:

RBS Investor RelationsMatt WaymarkHead of Investor RelationsTel: +44 (0) 20 7672 1758

 * Under the terms of the sale agreement, additional consideration may become payable in certain circumstances if the purchaser either resells Euroclear plc shares acquired pursuant to this transaction or acquires further shares in Euroclear plc, in each case at or above certain agreed pricing thresholds within a specified period following completion.

FORWARD LOOKING STATEMENTS

This announcement contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, including (but not limited to) those with respect to RBS and its subsidiaries' regulatory capital position, financial position, risk-weighted assets, profitability and financial performance and the implementation of RBS's transformation programme under certain specified scenarios. In addition, forward-looking statements may include, without limitation, statements containing words such as "intends", "believes", "expects", "anticipates", "targets", "plans", "will" and similar expressions or variations on these expressions. These statements concern or may affect future matters, such as RBS's future economic results, business and capital plans and ability to achieve current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed in, or implied by, the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, political, fiscal and regulatory developments, accounting standards, competitive conditions, technological developments, interest and exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBS's actual results are discussed in RBS's 2016 Annual Report and Accounts (ARA) and its interim results for the six-months ended 30 June 2017 and materials filed with, or furnished to, the United States Securities and Exchange Commission, including, but not limited to, RBS's most recent Annual Report on Form 20-F and Reports on Form 6-K. The forward-looking statements contained in this announcement speak only as of the date they are made or revised and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

Legal Entity Identifier: 2138005O9XJIJN4JPN90, RR3QWICWWIPCS8A4S074

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISMIBFTMBTTBFR
Date   Source Headline
15th Apr 20169:22 amRNSHolding(s) in Company
14th Apr 20165:32 pmRNSAllotment and Issue of New Ordinary Shares
11th Apr 20169:00 amRNSImpact of recent Liability Management Exercise
7th Apr 20162:32 pmRNSBlock listing Interim Review
7th Apr 201612:44 pmRNSPricing and Final Results
7th Apr 201612:43 pmRNSAnnouncement of Final Results
6th Apr 20165:20 pmRNSANNOUNCEMENT OF PRICING INFORMATION
1st Apr 20162:00 pmRNSNotice of AGM
31st Mar 20162:11 pmRNSTotal Voting Rights
31st Mar 20167:00 amRNSRBSG priced $1.5 billion Senior Notes
30th Mar 20161:04 pmRNSCASH TENDER OFFERS FOR EURO AND STERLING NOTES
30th Mar 20161:03 pmRNSCASH TENDER OFFERS ON CERTAIN US DOLLAR SECURITIES
29th Mar 20167:00 amRNSFILING OF ANNUAL REPORT ON FORM 20-F WITH THE SEC
22nd Mar 20167:50 amRNSRBS and HMT to retire the DAS
18th Mar 20162:31 pmRNSPublication of Final Terms
15th Mar 20168:45 amRNSMorgan Stanley European Financials Conference
8th Mar 20162:14 pmRNSDirector/PDMR Shareholding
7th Mar 20162:14 pmRNSPublication of Prospectus
29th Feb 20164:51 pmRNSTotal Voting Rights
29th Feb 20162:00 pmRNSDirector/PDMR Shareholding
26th Feb 20167:01 amRNSAnnual Report and Accounts 2015
26th Feb 20167:00 amRNSFinal Results
25th Feb 20165:36 pmRNSHome Member State Confirmations
25th Feb 20164:23 pmRNSDividend Declaration
4th Feb 20163:59 pmRNSRBS February 2016 Restatement
29th Jan 20162:55 pmRNSTotal Voting Rights
27th Jan 20167:00 amRNSTrading Statement
7th Jan 201611:02 amRNSHolding(s) in Company
6th Jan 201611:43 amRNSTotal Voting Rights
31st Dec 201510:50 amRNSTotal Voting Rights
17th Dec 20155:32 pmRNSAllotment and Issue of New Ordinary Shares
17th Dec 20158:59 amRNSAppointment of a Non-Executive Director
16th Dec 20157:27 amRNSUpdate on the disposal of Williams & Glyn - Amend
16th Dec 20157:00 amRNSUpdate on the disposal of Williams & Glyn
7th Dec 20157:20 amRNSDisposal of a portfolio of Irish Real Estate Loans
1st Dec 20157:07 amRNSStatement re 2015 stress test results
30th Nov 20153:15 pmRNSTotal Voting Rights
26th Nov 20155:19 pmRNSImpact of recent Liability Management Exercise
23rd Nov 20153:32 pmRNSPublication of Prospectus
19th Nov 20155:11 pmRNSDividend Declaration
12th Nov 201512:51 pmRNSRBS Investor Seminar: CIB
12th Nov 20159:54 amRNSDirector Declaration
10th Nov 20152:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20151:40 pmRNSVisa Europe Shareholding
30th Oct 20153:35 pmRNSTotal Voting Rights
30th Oct 201512:05 pmRNSDisposal
30th Oct 20157:05 amRNSSale of Remainder of Citizens Financial Group Inc.
30th Oct 20157:00 amRNSInterim Management Statement
15th Oct 20154:00 pmRNSHolding(s) in Company
14th Oct 20158:16 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.